Advertisement

Urinary System pp 381-392 | Cite as

Transitional Cell Carcinoma, Bladder, Rat

  • Bendicht U. Pauli
  • Achim D. Gruber
  • Ronald S. Weinstein
Part of the Monographs on Pathology of Laboratory Animals book series (LABORATORY)

Abstract

The earliest transitional cell carcinoma (TCC) cannot be detected with the naked eye, but its presence and papillary appearance on the luminal surface of the urinary bladder can be easily visualized with a stereomicroscope. As the cauliflower-like tumors reach 1 cm or greater in diameter, areas of necrosis and hemorrhage may be present. Tumors are frequently multifocal, but may become confluent and grossly fill the lumen of the bladder. The texture of the mass varies from soft to firm, depending upon the amount of tissue present. Invasion of the subepithelial connective tissue and of the muscle layers may be visible upon dissection. Metastases may occur in paraaortic lymph nodes and the lungs, but they are rare.

Keywords

Urothelial carcinoma transitional cell carcinoma (TCC) 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Altman NH, Goodman DG (1979) Neoplastic diseases. In: Baker HJ, Lindsey JR, Weisbroth SH (eds) The laboratory rat, vol 1. Biology and diseases. Academic. NewYork, pp 333–376Google Scholar
  2. Asamoto M, Cohen SM (1994) Prohibitin gene is overexpressed but not mutated in rat bladder and cell lines. Cancer Lett 83:201–207PubMedCrossRefGoogle Scholar
  3. Asamoto M, Mann AM, Cohen SM (1994a) P53 mutation is infrequent and might not give a growth advantage in rat bladder carcinogenesis in vivo. Carcinogenesis 15:455–458PubMedCrossRefGoogle Scholar
  4. Asamoto M, Mann AM, Macatee TL. Cohen SM (1994b) Mutations and expression of the gene in rat bladder carcinomas and cell lines. Mol Carcinog 9:236–244PubMedCrossRefGoogle Scholar
  5. Becci PJ, Thompson HJ, Grubbs CJ. Squire RA. Brown CC, Sporn MB, Moon RC (1979) A quantitative dosing schedule for the induction of TCCs in female F344 rats with the use of N-butyl-N-(4-hydroxybutyl) nitrosamines. J Natl Cancer lnst 62:187–191Google Scholar
  6. Boormann GA, Hollander CF (1974) High incidence of spontaneous urinary bladder and ureter tumors in the Brown Norway rat. J Natl Cancer Inst 52:1005–1008Google Scholar
  7. Burek JD, Hollander CF (1977) Incidence patterns of spontaneous tumors in BN/Bi rats. J Natl Cancer Inst 58:99–105PubMedGoogle Scholar
  8. Cho KR, Vogelstein B (1992) Genetic alterations in the adenoma carcinoma sequence. Cancer [Suppl] 6:1727- 1731Google Scholar
  9. Clayson DB (1975) Experimental studies in urothelial cancer. In: Cooper EH, Williams RE (eds) The biology and clinical management of bladder cancer. Blackwell. Oxford, pp 1–35Google Scholar
  10. Cohen SM 1983 Pathology of experimental bladder cancer in rodents. In: Bryan GT. Cohen SM (eds) The pathology of bladder cancer. vol 2. CRC Press. Boca Raton, pp 1–40.Google Scholar
  11. Cohen SM 1983 Promotion of urinary bladder carcinogenesis. In: Langenbach R. Nesnow S, Rice JM (eds) Organ and species specificity in chemical carcinogenesis. Basic life sciences. Plenum, New York. pp 253–272Google Scholar
  12. Cohen SM, Jacobs JB. Arai M. Johansson S. Friedell GH (1976) Early lesions in experimental bladder cancer. Experimental design and light microscopic findings. Cancer Res 36:2508–2511PubMedGoogle Scholar
  13. Coleman GL, Barthold SW. Osbaldiston GW. Foster SJ. Jonas AM (1977) Pathological changes during aging in barrier-reared Fischer 344 male rats. J Gerontol 32:258- 278PubMedGoogle Scholar
  14. Coombs LK, Pigott DA, Sweeney E. Procter AJ. Eydmann ME, Parkinson C, Knowles MA (1991) Amplification and over expression of c-erbB-2 in TCC of the urinary bladder. Br 1 Cancer 63:601–608CrossRefGoogle Scholar
  15. DeMeester LJ, Farrow GM. Utz DC (1975) Inverted papillomas of the bladder. Cancer 36:505–513.PubMedCrossRefGoogle Scholar
  16. Erttirk E, Price JM. Morris JE. Cohen S, Leith RS. Von Esch AM, Crovetti AJ (1967) The production of carcinoma of the urinary bladder in rats by feeding N-[3- (5-nitro-2-furyl)-2-thiazolyl] formamide. Cancer Res 27:1998–2002Google Scholar
  17. Erttirk E, Cohen SM, Price JM, Bryan GT (1969) Pathogenesis, histology, and transplantability of bladder carcinomas induced in albino rats by oral administration of N-[4-(5-nitro-2-furyl)-2-thiamolyl) formamide. Cancer Res 29:2219–2228Google Scholar
  18. Foulds L (1969) Neoplastic development, vol 1. Academic, New York.Google Scholar
  19. Frith CH. Eighmy JJ, Fukushima S. Cohen SM, Squire RA, Chandra M (1995) Proliferative lesions of the urinary tract in rats. In: Guides for toxicologic pathology. STP/ARP/AFIP, Armed Forces Institute of Pathology, Washington DCGoogle Scholar
  20. Fukushima C. Cohen SM. Arai M, lacob JB, Friedell GH (1981) Scanning electron microscopic examination of reversible hyperplasia of the rat urinary bladder. Am J Pathol 102:373–380PubMedGoogle Scholar
  21. Fukushima S, Hirose M. Tsuda H, Shirai T. Hirao K (1976) Histological classification of urinary bladder cancer in rats induced by N-butyl-N-(4-hydroxybutyl)nitrosamine. Gann 67:81–90PubMedGoogle Scholar
  22. Goodman DG, Ward JM, Squire RA, Chu KC, Linhart MS (1979) Neoplastic and nonneoplastic lesions in aging F344 rats. Toxicol Appl Pharmacol 48:237–248PubMedCrossRefGoogle Scholar
  23. Herman CJ, Vegt PD, Debruyne FM. Vooijs GP, Ramaekers FC (1985) Squamous and transitional elements in rat bladder carcinomas induced by Nbutyl- N-(4-hydroxybutyl)nitrosamine (BBN). A study of cytokeratin expression. Am J Pathol 120:419- 426PubMedGoogle Scholar
  24. Hicks RM, Chowaniec J (1978) Experimental induction, histology. and ultrastructure of hyperplasia and neoplasia of the urinary epithelium. Int Rev Exp Pathol 18:199–280PubMedGoogle Scholar
  25. Ishak KG, Legolvan PC. El-Sebai I (1967) Malignant bladder tumors associated with schistosomiasis. A gross and microscopic study. Mostofi FK (ed) Bilharziasis. Springer. Berlin Heidelberg New York. pp 58–83Google Scholar
  26. Iwata H, Otoshi T, Takada N, Murai T. Tamano S, Watanabe T, Katsura Y, Fukushima S (1995) Validation of silver-stained nucleolar organizer regions for evaluation of invasive character of urinary bladder carcinoma in rats and mice. Urol Res 23:27–32PubMedCrossRefGoogle Scholar
  27. Jacobs JB, Arai K, Cohen SM. Friedell GH (1976) Early lesions in experimental bladder cancer: scanning electron microscopy of cell surface markers. Cancer Res 36:2512–2517PubMedGoogle Scholar
  28. Jacobs JB. Arai M. Cohen SM, Friedell GH (1977) A longterm study of reversible and progressive bladder cancer lesions in rats fed N-[4-(5-nitro-2-furyl)-2-thiazolyl] formamide. Cancer Res 37:2817–2821PubMedGoogle Scholar
  29. Jewett HJ (1951) Carcinoma of the bladder: influence of depth of infiltration on the 5-year results following complete extirpation of the primary growth. J Urol 67:672- 676Google Scholar
  30. Kobayashi I (1989) Changes in cell surface carbohydrate antigens in bladder carcinogenesis. Nishinihon J Urol 51:13–20Google Scholar
  31. Koss LG (1969) The asymmetric unit membranes of the epithelium of the urinary bladder of the rat. An electron microscopic study of a mechanism of epithelial maturation and function. Lab Invest 21:154–168PubMedGoogle Scholar
  32. Koss LG (ed) (1975) Tumors of the urinary bladder. Second series. fascicle 11. Armed Forces Institute of Pathology, Washington DCGoogle Scholar
  33. Kunze E (1979) Development of urinary bladder cancer in rat. In: Grundmann E (ed) Carcinogenesis. Springer. Berlin Heidelberg New York, pp 145–232 (Current topics in pathology, vol 67)Google Scholar
  34. MacKenzie WF, Garner FM (1973) Comparison of neoplasms in six sources of rats. J Natl Cancer Inst 50:1243- 1257Google Scholar
  35. Mann AMK, Asamoto M, Masui T, Macatee T, Eklund SH, Cohen SM (1994) neu is not involved in N-[4-(5- nitro-2-furyl) 2-thiazolyl] formamide-induced bladder carcinoma or 2-amino-4-(5-nitro-2-furyl) thiazole transformation of rat bladder epithelial cells. Cancer Lett 84:125–131Google Scholar
  36. Masui T, Mann AM, Macatee TL, Okamura T, Garland EM, Fujii H, Pelling JC, Cohen SM 1991 H-ras mutations in rat urinary bladder carcinomas induced by N-[4- (5-nitro-2-furyl)2-thiazolyl] formamide and sodium saccharin, sodium ascorbate, or related salts. Cancer Res 51:3471–3475PubMedGoogle Scholar
  37. Masui T, Ward JM, Cohen SM (1991b) Enhanced immunoreactivity of ras oncogene p21 protein in urinary bladder epithelium of rats treated with N-[4-(5-nitro-2- furyl)-2-thiazolyl] formamide. Cancer Lett 59:95–102PubMedCrossRefGoogle Scholar
  38. Masui T, Mann AM, Macatee TL, Okamura T, Garland EM, Smith RA, Cohen SM (1992) Absence of ras oncogene activation in rat urinary bladder carcinomas induced by N-methyl-N-nitrosourea or N-butyl-N-(4- hydroxybutyl)nitrosamine. Carcinogenesis 13:2281- 2285PubMedCrossRefGoogle Scholar
  39. Moll R, Achtstatter T, Becht E, Balcarova-Stander J, Ittensohn M, Franke W (1988) Cytokeratins in normal and malignant urothelial epithelium. Maintenance of expression of urothelial cell culture lines. Am J Pathol 132:123–144PubMedGoogle Scholar
  40. Pamukcu AM, Erttirk E, Yalciner S, Bran GT (1976) Histogenesis of urinary bladder cancer induced in rats by bracken fern. Invest UroI 14:213–218Google Scholar
  41. Pauli BU, Weinstein RS (1986) FANFT rat bladder carcinogenesis: a model system in vivo and in vitro. In: Webber MM, Sekely L (eds) In vitro models for cancer research. CRC Press, Boca Raton, pp 169–200Google Scholar
  42. Pauli BU, Weinstein RS, Alroy J, Arai M (1977) Ultrastructure of cell junctions in FANFT-induced urothelial tumors in urinary bladder of Fischer rats. Lab Invest 37:609–621PubMedCrossRefGoogle Scholar
  43. Pauli BU, Alroy J, Weinstein RS 1983 Ultrastructure and pathobiology of urinary bladder cancer. In: Bryan GT, Cohen SM (eds) The pathology of bladder cancer, vol 2. CRC Press, Boca Raton, pp 41–140Google Scholar
  44. Pauli BU, Cohen SM, Weinstein RS 1983 Cellular changes rat urinary bladder carcinomas induced by F ANFT: a quantitative electron microscopic analysis. J Urol 129:646–652PubMedGoogle Scholar
  45. Prejean JD, Peckham JC, Casey AE, Griswold DP, Weisburger EK, Weisburger JH (1973) Spontaneous tumors in Sprague Dawley rats and Swiss mice. Cancer Res 33:2768–2773PubMedGoogle Scholar
  46. Ramaekers F, Huysmans F, Moesker O, Schaart G, Herman C, Vooijs P (1985) Cytokeratin expression during neoplastic progression of human transitional cell carcinomas as detected by monoclonal and polyclonal antibodies. Lab Invest 52:31–38PubMedGoogle Scholar
  47. Ravery V, Jouanneau J, Gil-Diez S, Abbou CC, Caruelle JP, Barritault D, Chopin DK (1992) Immunohistochemical detection of acidic fibroblast growth factor in bladder transitional cell carcinoma. Urol Res 20:211- 214PubMedCrossRefGoogle Scholar
  48. Recker F, Otto T, Rubben H (1992) Lectins in diagnosis of bladder carcinoma. Urol Int 48:149–153PubMedCrossRefGoogle Scholar
  49. Reedy EA, Heatfield BM, Trump BF, Resau JH (1990) Correlation of cytokeratin patterns with histopathology during neoplastic progression in the rat urinary bladder. Pathobiology 58:15–27PubMedCrossRefGoogle Scholar
  50. Sass B, Rabstein LS, Madison R, Nims RM, Peters RL, Kelloff GJ (1975) Incidence of spontaneous neoplasms in F344 rats throughout the natural life-span. J Nat! Cancer Inst 54:1449–1456PubMedGoogle Scholar
  51. Sato T, Saito H, Swenson J, Olifant A, Wood C, Danner D, Sakamoto T, Takita K, Kasumi F, Miki Y (1992) The human prohibitin gene located on chromosome 17q21 is mutated in sporadic breast cancer. Cancer Res 52:1643–1646PubMedGoogle Scholar
  52. Skinner DG (1977) Current state of classification and staging of bladder cancer. Cancer Res 37:2838–2842PubMedGoogle Scholar
  53. Snell KC (1965) Spontaneous lesions of the rat. In: Ribelin WE, McCoy JR (eds) The pathology of laboratory animals. Thomas, Springfield, pp 241–302Google Scholar
  54. Squire RA, Sporn MB, Brown CC, Smith JM, Wenk ML, Springer S (1977) Histopathological evaluation of the inhibition of rat bladder carcinogenesis by 13-cis-retinoic acid. Cancer Res 37:2930–2936PubMedGoogle Scholar
  55. Takeuchi T, Tanaka T, Ohno T, Yamamoto N, Kobayashi S, Kuriyama M, Kawada Y, Mori H (1990) Nucleolar organizer regions in rat urinary bladder tumors induced by N-butyl-N-(4hydroxybutyl)nitrosamine. Virchows Arch B Cell Pathol 58:383–387Google Scholar
  56. Tsuda H, Inoue T, Asamoto M, Fukushima S, Ito N, Okamura T, Ohtaguro K, Washida H, Satoh K (1989) Comparison of enzyme phenotypes in human bladder tumors and experimentally induced hyperplastic and neoplastic lesions of the rat urinary bladder. A combined histochemical and immunochemical approach. Virchows Arch B Cell Pathol 56:307–316Google Scholar
  57. Van Moorselaar RJA, Ichikawa T, Schaafsma BE, Jap PHK, Isaacs JT, VanStratum P, Ramaekers FCS, Debruyne FMJ, Schalken JA (1993) The rat bladder tumor model system RBT resembles phenotypically human superficial transitional cell carcinoma. Urol Res 21:413–421PubMedCrossRefGoogle Scholar
  58. Weinstein RS, Koo C, Pauli BU, Jacobs JB, Friedell GH (1979) Epithelial injury by cystoscopy fluids. Semin Oncol 6:257–259PubMedGoogle Scholar
  59. Zhang XH, Takenaka I (1994) Basement membrane and tumor invasion: ultrastructural observations in the basement membrane of rat bladder with invasive transitional cell carcinoma induced by N-butyl-N-(4- hydroxylbutyl)nitrosamine. Urol Res 22:317–321PubMedCrossRefGoogle Scholar
  60. Zhang X, Matsuoka N, Sugimoto M, Takenaka I (1994) Basement membrane and carcinogenesis: ultrastructural observations in the basement membrane of the bladder epithelium in rats treated with N-butyl-N-(4- hydroxybutyl)nitrosamine (BBN). Int J Urol 1:129–134PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1998

Authors and Affiliations

  • Bendicht U. Pauli
  • Achim D. Gruber
  • Ronald S. Weinstein

There are no affiliations available

Personalised recommendations